We are currently in the process of upgrading the members area of the website, you will be unable to access membership specific files while the upgrade is in progress. To manage your membership please access my.bsgm.org.uk.

Start Date: 08/06/2017

End Date: 08/06/2017

Cost: 210

Venue: Central London

Organiser:

Westminster Forum Projects

Contact Details:

The future of biosimilars in the UK: regulation, access and medicines optimisation

Thursday, 8th June 2017

Central London

 

Guest of Honour

 

Dr Christian Schneider, Director, National Institute for Biological Standards and Control, MHRA

 

This seminar will provide the opportunity to discuss the future of biosimilar medicines in the UK.

Delegates will assess the next steps for regulation and pharmacovigilance, the impact of increased competition between originator and biosimilar manufacturers and the challenges for embedding use in service delivery following the publication of NHS England’s ‘What is a biosimilar medicine?’ guide.

Sessions will also focus on the implications of the UK vote to leave the European Union on access to biosimilars, key issues for clinicians around switching from originator to biosimilar - and the next steps for patient engagement, education and involvement.

Link: www.westminsterforumprojects.co.uk/conference/biosimilars-17/21565

    Latest News

  • BSGM submission to the Science and Technology Committee inquiry

    posted 18th April 2017  |  0 Comments

    The BSGM has made a submission to the Science and Technology Committee (Commons) inquiry on genomics and genome-editing. For more details about the scope of the inquiry and details of other submissions see - http://www.parliament.uk/business/committees/committees-a-z/commons-select/science-and-technology-committee/inquiries/parliament-2015/inquiry2/

    Read more